Cancer treatment

Cancer treatment encompasses a wide array of therapeutic strategies aimed at controlling or eliminating cancerous cells within the body. These strategies include chemotherapy, radiation therapy, immunotherapy, targeted therapy, and surgical interventions. Each treatment modality targets different aspects of cancer cell biology, such as cell division, DNA replication, or immune evasion. Research in cancer treatment focuses on improving the efficacy, specificity, and safety of these therapies to enhance patient outcomes and reduce side effects. At CymitQuimica, we provide a comprehensive range of compounds and reagents to support your research in developing innovative and effective cancer treatments.

20
- 50
- 100
- 200

products per page. 959 products on this category.

Product data	Purity	Price range	Estimated delivery
Bestatin Impurity 21 REF: 4Z-B-119024	- - -	To inquire	Tue 10 Dec 24
Olaparib Impurity 72 REF: 4Z-O-032077	- - -	To inquire	Tue 10 Dec 24
Bestatin Impurity 23 REF: 4Z-B-119026	- - -	To inquire	Tue 10 Dec 24
Enzalutamide Impurity A REF: 4Z-E-068006CAS: 112704-79-7	- - -	To inquire	Tue 10 Dec 24
Fulvestrant Impurity 10 REF: 4Z-F-3132	- - -	To inquire	Tue 10 Dec 24
Palbociclib Impurity 50 REF: 4Z-P-196057	- - -	To inquire	Tue 10 Dec 24
Didesmethyl Tamoxifen REF: 4Z-T-016	- - -	To inquire	Tue 10 Dec 24
Nintedanib Impurity 62 DiHCl REF: 4Z-N-066080CAS: 5395-70-0 623-09-6	- - -	To inquire	Tue 10 Dec 24
N-Desmethyl tamoxifen-d5 HCl REF: 4Z-T-012CAS: 10540-29-1	- - -	To inquire	Tue 10 Dec 24
Lenvatinib Impurity 40 REF: 4Z-L-124046	- - -	To inquire	Tue 10 Dec 24
Carfilzomib Impurity 35 REF: 4Z-C-121038CAS: 2177287-68-0	- - -	To inquire	Tue 10 Dec 24
Carfilzomib Impurity 39 REF: 4Z-C-121042CAS: 875309-82-3	- - -	To inquire	Tue 10 Dec 24
N-Nitroso Enzalutamide Impurity 7 REF: 4Z-E-068069	- - -	To inquire	Tue 10 Dec 24
Nintedanib Impurity 63 REF: 4Z-N-066081CAS: 2243384-71-4	- - -	To inquire	Tue 10 Dec 24
Bestatin Impurity 29 REF: 4Z-B-119035	- - -	To inquire	Tue 10 Dec 24
Fulvestrant Impurity 4 REF: 4Z-F-3117CAS: 1621885-82-2	- - -	To inquire	Tue 10 Dec 24
Nintedanib Impurity 72 (Intedanib Impurity 72) REF: 4Z-N-066006CAS: 1610881-60-1	- - -	To inquire	Tue 10 Dec 24
Nintedanib Impurity 49 REF: 4Z-N-066067CAS: 380427-39-4	- - -	To inquire	Tue 10 Dec 24
Carfilzomib Impurity 49 REF: 4Z-C-121052	- - -	To inquire	Tue 10 Dec 24
Fulvestrant R Enantiomer REF: 4Z-F-3137CAS: 1316849-17-8	- - -	To inquire	Tue 10 Dec 24

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

Cancer treatment

Bestatin Impurity 21

Ref: 4Z-B-119024

Olaparib Impurity 72

Ref: 4Z-O-032077

Bestatin Impurity 23

Ref: 4Z-B-119026

Enzalutamide Impurity A

Ref: 4Z-E-068006

Fulvestrant Impurity 10

Ref: 4Z-F-3132

Palbociclib Impurity 50

Ref: 4Z-P-196057

Didesmethyl Tamoxifen

Ref: 4Z-T-016

Nintedanib Impurity 62 DiHCl

Ref: 4Z-N-066080

N-Desmethyl tamoxifen-d5 HCl

Ref: 4Z-T-012

Lenvatinib Impurity 40

Ref: 4Z-L-124046

Carfilzomib Impurity 35

Ref: 4Z-C-121038

Carfilzomib Impurity 39

Ref: 4Z-C-121042

N-Nitroso Enzalutamide Impurity 7

Ref: 4Z-E-068069

Nintedanib Impurity 63

Ref: 4Z-N-066081

Bestatin Impurity 29

Ref: 4Z-B-119035

Fulvestrant Impurity 4

Ref: 4Z-F-3117

Nintedanib Impurity 72 (Intedanib Impurity 72)

Ref: 4Z-N-066006

Nintedanib Impurity 49

Ref: 4Z-N-066067

Carfilzomib Impurity 49

Ref: 4Z-C-121052

Fulvestrant R Enantiomer

Ref: 4Z-F-3137